• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Dyax Corp. (DYAX)

    -NasdaqGM
    26.31 Down 0.33(1.24%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:26.64
    Open:26.79
    Bid:22.96 x 500
    Ask:29.08 x 1000
    1y Target Est:29.75
    Beta:0.73
    Earnings Date:Jul 27 - Jul 31 (Est.)
    Day's Range:26.16 - 26.79
    52wk Range:8.09 - 30.55
    Volume:548,976
    Avg Vol (3m):1,451,680
    Market Cap:3.83B
    P/E (ttm):N/A
    EPS (ttm):-0.10
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    DYAXDown 1.24%3.83B
    SHPGUp 1.04%48.32B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):44.09
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.19
    Quarterly EPS Est (Jun-15) :-0.04
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):-7.42

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and other plasma-kallikrein-mediated (PKM) disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback